(Q46718272)

English

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine

scientific article published in October 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

A cost-effectiveness analysis of alternative disease management strategies in patients with Crohn's disease treated with azathioprine or 6-mercaptopurine (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

Crohn's disease

1 reference

based on heuristic

inferred from title

0 references

William Jeffery Sandborn

6

object named as

William J Sandborn

1 reference

Europe PubMed Central

24 December 2017

author name string

Marla C Dubinsky

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Eileen Reyes

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Joshua Ofman

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Chiun-Fang Chiou

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Sally Wade

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

100

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

2239-2247

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41900.X

21 January 2018

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41900.X

21 January 2018

Cost-effectiveness of thiopurine methyltransferase genotype screening in patients about to commence azathioprine therapy for treatment of inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41900.X

21 January 2018

Optimizing the Therapeutic Potential of Azathioprine/6-Mercaptopurine in the Treatment of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41900.X

21 January 2018

Rational dosing of azathioprine and 6-mercaptopurine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2005.41900.X

21 January 2018

Identifiers

10.1111/J.1572-0241.2005.41900.X

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/16181376

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46718272&oldid=2128033181"